Skip to main content
. Author manuscript; available in PMC: 2017 Mar 15.
Published in final edited form as: Acta Biomater. 2016 Jan 27;33:34–39. doi: 10.1016/j.actbio.2016.01.039

Fig. 5.

Fig. 5

Anti-cancer efficacy of i.v.-injected formulations in animals with subcutaneous MDA-MB-231 tumors. a) Effect of treatment on tumor volume. Groups with GMP contained 50 mg/kg. (b) Final weights of tumor tissues 28 days after i.v. injection. Data are medians ± quartiles (N=5). Asterisks indicate P < 0.05.